Pursuant
to Rule 17f-2 [17 CFR 270.17f-2]
1.
Investment Company Act File Number: 811-22684
|
|
Date
examination completed:
|
|
|
|
|
|
|
|
October
31, 2020
|
2.
State identification Number:
|
|
|
AL
|
|
AK
|
|
AZ
|
|
AR
|
|
CA
|
|
CO
|
|
|
CT
|
|
DE
|
|
DC
|
|
FL
|
|
GA
|
|
HI
|
|
|
ID
|
|
IL
|
|
IN
|
|
IA
|
|
KS
|
|
KY
|
|
|
LA
|
|
ME
|
|
MD
|
|
MA
|
|
MI
|
|
MN
|
|
|
MS
|
|
MO
|
|
MT
|
|
NE
|
|
NV
|
|
NH
|
|
|
NJ
|
|
NM
|
|
NY
X
|
|
NC
|
|
ND
|
|
OH
|
|
|
OK
|
|
OR
|
|
PA
|
|
RI
|
|
SC
|
|
SD
|
|
|
TN
|
|
TX
|
|
UT
|
|
VT
|
|
VA
|
|
WA
|
|
|
WV
|
|
WI
|
|
WY
|
|
PUERTO
RICO
|
|
|
|
|
|
|
Other
(specify):
|
|
|
|
|
|
|
|
|
|
|
3.
Exact name of investment company as specified in registration statement:
|
|
Daxor
Corporation
|
|
4.
Address of principal executive office (number, street, city, state, zip code):
|
|
350
Fifth Avenue, Suite 4740, New York, New York 10118
|
MANAGEMENT
STATEMENT REGARDING COMPLIANCE WITH CERTAIN PROVISIONS OF THE INVESTMENT COMPANY ACT OF 1940
December
22, 2020
We,
as members of management of Daxor Corporation (the “Company”), are responsible for complying with the requirements
of subsections (b) and (c) of Rule 17f-2, “Custody of Investments by Registered Management Investment Companies,”
of the Investment Company Act of 1940. We are also responsible for establishing and maintaining effective internal controls over
compliance with those requirements. We have performed an evaluation of the Company’s compliance with the requirements of
subsections (b) and (c) of Rule 17f-2 as of October 31, 2020, and from September 1, 2020 through October 31, 2020.
Based
on this evaluation, we assert that the Company was in compliance with the requirements of subsections (b) and (c) of Rule 17f-2
of the Investment Company Act of 1940 as of October 31, 2020, and from September 1, 2020 through October 31, 2020, with respect
to securities reflected in the investment accounts of the Company.
Daxor
Corporation
/s/
Michael Feldschuh
|
|
Michael
Feldschuh
|
|
President
and Chief Executive Officer
|
|
|
|
/s/
Robert J. Michel
|
|
Robert
J. Michel
|
|
Chief
Financial Officer
|
|
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To
the Management and Board of Directors of
Daxor
Corporation
We
have examined management’s assertion, included in the accompanying Management Statement Regarding Compliance with Certain
Provisions of the Investment Company Act of 1940, that Daxor Corporation (the “Company”) complied with the requirements
of subsections (b) and (c) of Rule 17f-2 under the Investment Company Act of 1940 as of October 31, 2020. Management is responsible
for the Company’s assertion about compliance with the requirements of subsections (b) and (c) of Rule 17f-2 of the Act (the
“specified requirements”). Our responsibility is to express an opinion on management’s assertion about the Company’s
compliance with the specified requirements based on our examination.
Our
examination was conducted in accordance with attestation standards established by the American Institute of Certified Public Accountants
and the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform
the examination to obtain reasonable assurance about whether management’s assertion about compliance with the specified
requirements is fairly stated, in all material respects. An examination involves performing procedures to obtain evidence about
whether management’s assertion is fairly stated in all material respects. The nature, timing and extent of the procedures
selected depend on our judgment, including an assessment of the risks of material misstatement of management’s assertion,
whether due to fraud or error. We believe that the evidence we obtained is sufficient and appropriate to provide a reasonable
basis for our opinion. Included among our procedures were the following tests performed as of October 31, 2020, and with respect
to agreement of security purchases and sales, for the period from September 1, 2020 (the date of our last examination, August
31, 2020) through October 31, 2020:
|
●
|
Confirmation
of all securities held by institutions in book entry form with UBS Financial Services, Inc.
|
|
|
|
|
●
|
Reconciliation
of all such securities to the books and records of the Company and the Custodian.
|
|
|
|
|
●
|
Agreement
of a representative sample of 4 security transactions for the period from September 1, 2020 through October 31, 2020 from
the books and records of the Company to broker confirmations.
|
We
believe that our examination provides a reasonable basis for our opinion. Our examination does not provide a legal determination
on the Company’s compliance with specified requirements.
In
our opinion, management’s assertion that Daxor Corporation complied with the requirements of subsections (b) and (c) of
Rule 17f-2 of the Investment Company Act of 1940 as of October 31, 2020, with respect to securities reflected in the investment
account of the Company is fairly stated, in all material respects.
This
report is intended solely for the information and use of management and the Board of Directors of Daxor Corporation and the Securities
and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.
/s/
WithumSmith+Brown, PC
New
York, New York
December
22, 2020
Daxor (AMEX:DXR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Daxor (AMEX:DXR)
Historical Stock Chart
From Oct 2023 to Oct 2024